Results 211 to 220 of about 60,399 (263)

Necessary, Legendary and Detrimental Components of Human Colorectal Organoid Culture Medium: Raising Awareness to Reduce Experimental Bugs. [PDF]

Cancers (Basel)
Benelli R.
europepmc   +1 more source

RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma. [PDF]

J Biol Chem
Feng J, Ye L, Chen C, Zhu Y, Liu R, Yu H, Lu L, Gong K, Li W.   +8 more
europepmc   +1 more source

Unraveling the Impact of KRAS Accessory Proteins on Oncogenic Signaling Pathways. [PDF]

Cells
Garg V, Hofmann RNHM, Saleem M, Mirzaiebadizi A, Hashemi GS, Hameed T, Jooyeh B, Pudewell S, Mehrabipour M, Mosaddeghzadeh N, Piekorz RP, Ahmadian MR.   +11 more
europepmc   +1 more source

Mechanisms of ferroptosis in primary hepatocellular carcinoma and progress of artificial intelligence-based predictive modeling in hepatocellular carcinoma. [PDF]

World J Gastroenterol
Han JF, Jia ZY, Fan X, Zhao XY, Cheng LY, Xia YX, Ji XR, Zang WQ.   +7 more
europepmc   +1 more source

Pathway-Specific Therapeutic Modulation of Melanoma: Small-Molecule Inhibition of BRAF-MEK and KIT Signaling in Contemporary Precision Oncology with a Special Focus on Vemurafenib, Trametinib, and Imatinib. [PDF]

J Clin Med
Kawczak P, Bączek T.
europepmc   +1 more source

Sulindac as a precision microRNA modulator in early-stage K-Ras-driven oncogenesis. [PDF]

Cell Death Discov
Adamopoulos C, Papavassiliou KA, Papavassiliou AG.   +2 more
europepmc   +1 more source

Targeting Ferroptosis to Overcome Drug Resistance in Cancer: Molecular Mechanisms and Therapeutic Prospects. [PDF]

Biomol Ther (Seoul)
Joo SH, Cho YY, Shim JH.
europepmc   +1 more source

CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway. [PDF]

Oncol Res
Zhang S, Li J, Jin Q, Zhu S, Yan H, Wang Y, Song Z, Liu L.   +7 more
europepmc   +1 more source

Anti-tumor efficacy of RAF/MEK inhibitor VS6766 in KRAS-mutated colorectal cancer cells. [PDF]

Cancer Chemother Pharmacol
Zhu H, Yan G, Ma J, Zhang B, Yan Y, Zhu L, Dong R, Lin N, Tan B.   +8 more
europepmc   +1 more source

Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review. [PDF]

J Enzyme Inhib Med Chem
Liu P, Liu Y, Cheng L, Bao T, Li J, Wu J, Han J, Li T, Zhang D.   +8 more
europepmc   +1 more source